CoChat

Progress in hematopoietic stem cell transplantation as allogeneic cellular gene therapy in thalassemia

Isgrò, Antonella, Gaziev, Javid, Sodani, Pietro, Lucarelli, Guido · 2010 · Annals of the New York Academy of Sciences
Cited by 46

The DOI matches its Crossref record.

Abstract

Allogeneic hemopoietic stem cell transplantation (HSCT) represents one of the best cures for thalassemia. Currently, HSCT for thalassemia consists of allogeneic stem cell gene therapy and still awaits autologous genetically modified stem cell transplantation. HSCT for thalassemia has substantially improved over the last two decades, due in large part to improvements in preventive strategies, the effective control of transplant‐related complications, and the development of new preparative regimens. A risk classes‐based approach to transplantation in thalassemia has led to disease‐free survival probability of 87, 85, and 80% in classes 1, 2, and 3 patients, respectively. Adult thalassemia patients, who are higher risk patients for transplant‐related toxicity due to an advanced phase of the disease, have a cure rate of 65% with current treatment protocol. Patients who do not have matched family or unrelated donors could benefit from haploidentical mother‐to‐child transplantation. Overall, the results of this type of transplantation appear encouraging.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1749-6632.2010.05543.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 46

Metadata

Authors
Isgrò, A., Gaziev, J., Sodani, P., & Lucarelli, G.
Venue
Annals of the New York Academy of Sciences
Publisher
Wiley
Published
2010-08
Volume
1202
Issue
1
Pages
149-154
ISSN
  • 0077-8923 (ISSN-L)
  • 1749-6632
OpenAlex
W1647977202
Cited by
46
References
0
FWCI
2.15
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Progress in hematopoietic stem cell transplantation as allogeneic cellular gene therapy in thalassemia. https://app.cochat.ai/papers/10.1111/j.1749-6632.2010.05543.x
The paper
Isgrò, A., Gaziev, J., Sodani, P., & Lucarelli, G. (2010). Progress in hematopoietic stem cell transplantation as allogeneic cellular gene therapy in thalassemia. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.2010.05543.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.